期刊文献+

非劣效性设计临床试验 被引量:5

Noninferiority Design Clinical Trials
下载PDF
导出
摘要 非劣效性设计临床试验是一类检验试验组治疗手段是否不劣于对照组治疗手段的随机对照临床试验。本文简要介绍非劣效性设计临床试验的基本概念、设计要点及其与等效性和优效性设计临床试验的差异,并通过具体案例解读,帮助读者全面了解、实施和评价非劣效性设计方法。 A noninferiority design clinical trial is a type of randomized controlled clinical trials that examines whether the treatment of the experimental group is not inferior to the treatment of the control group.This paper introduces the basic concept,design points,comparison with equivalence and superiority trials,and case analysis to help readers fully understand,implement and evaluate noninferiority design clinical trials.
作者 周齐 严鸿伊 张艳丽 潘岳松 ZHOU Qi;YAN Hongyi;ZHANG Yanli;PAN Yuesong(Beijing Tiantan Hospital,Capital Medical University,National Clinical Research Center for Neurological Diseases,Beijing 100070,China)
出处 《中国卒中杂志》 2023年第6期636-644,共9页 Chinese Journal of Stroke
基金 国家重点研发计划(2022YFC3602500)。
关键词 临床研究 随机对照试验 非劣效 界值 Clinical trial Randomized controlled trial Noninferiority Margin
  • 相关文献

参考文献9

二级参考文献74

  • 1FDA. Antibacterial drug products: use of non - inferiority studies to support approval [ EB/OL]. http://www. fda. gov/cder/guidance/ 7884dft. pdf. ,2007 - 10 - 12.
  • 2International Conference on Harmonisation Guidance. Guidance EIO. Choice of control group and related issues in clinical trials [ EB/OL]. http//www. emea. europa eu/pdfs/human/ich/036496en, pdf. , 2000 -07 -01.
  • 3Jaeschke R, Singer J, Guyatt G H. Measurement of health status. Ascertaining the minimal clinically important difference [J]. Control Clin Trials, 1989, 10(4) : 407-415.
  • 4Jaeschke R, Guyatt G H, Keller J, et al. Interpreting changes in quality-of-life score in N of 1 randomized trials [ J ]. Control Clin Trials, 1991, 12(4 Suppl): 226S-2335.
  • 5Stratford P W, Binkley J M, Riddle D L, et al. Sensitivity to change of the Roland- Morris Back Pain Questionnaire : part 1 [J]. Phys Ther, 1998, 78(11): 1186-1196.
  • 6van Walraven C, Mahon J L, Moher D, et al. Surveying physicians to determine the minimal important difference: implications for sample- size calculation [ J ] . J Clin Epidemiol, 1999, 52(8) : 717-723.
  • 7van der Roer N, Ostelo R W, Bekkering G E, et al. Minimal clinically important change for pain intensity, functional status, and general health status in patients with nonspecific low back pain [J]. Spine, 2006, 31(5): 578-582.
  • 8Beaton D E, Boers M, Wells G A. Many faces of the minimal clinically important difference ( MCID ) : a literature review and directions for future research [ J ]. Curr Opin Rheumatol, 2002, 14(2) : 109-114.
  • 9Beaton D E. Understanding the relevance of measured change through studies of responsiveness [ J ] . Spine, 2000, 25 (24) : 3192-3199.
  • 10Hagg O, Fritzell P, Nordwall A, et al. The clinical importance of changes in outcome scores after treatment for chronic low back pain [ J]. Eur Spine J, 2003, 12(1 ) : 12- 20.

共引文献80

同被引文献69

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部